Nadir Arber, a holder of M.D. and M.S. degrees, is a Full Professor of medicine and gastroenterology, and is a Holder of the Yechiel and Helen Lieber Chair for Cancer Research at Tel Aviv Souraski Medical Center and Tel Aviv University. Dr. Arber is currently heading the grants committee of the Sackler School of Medicine at Tel Aviv University. Dr. Arber, a noted expert in the field of early detection and prevention, has been serving as the Principal Investigator (PI) of the ICPC research laboratory and in several international, multicenter clinical trials in the field of early detection, prevention, and therapy of gastrointestinal (GI) malignancies using NSAIDs and, in particular, colorectal cancer (CRC). Dr. Arber graduated at the Medical School in Hadassah, Jerusalem, in 1987. Residency in internal medicine was performed at the Rabin Medical Center (1987–1991) in addition to a fellowship in gastroenterology at Tel Aviv Souraski Medical Center (1991–1993). Three years of a research fellowship were performed in Columbia University, NY, at the laboratory of Dr. Bernard Weinstein. Since 1999, Dr. Arber has been the Head of the GI Oncology Unit at the Department of Gastroenterology, Tel Aviv Souraski Medical Center. In 2002, he became the Head of the ICPC. His department has a significant and diverse experience in translational research focused on early detection, prevention, and therapy of cancer, in particular tumors of the GI tract. Dr. Arber has extensive experience in clinical studies, molecular epidemiology, as well as in molecular and cell biology studies of cancer. He had published more than 302 articles in peer-reviewed journals, reviews and chapters in books, and received more than 90 research grants and awards. Currently, his ongoing research focuses on translational research, bridging between basic research in the lab and clinicians and patients in the clinical center.
Biography Updated on 4 November 2012